Skip to main content
Back to feed
HealthSingle-sourceMedium
5.3

NHS England approves Fampridine for multiple sclerosis mobility treatment

NHS England has authorized the use of Fampridine to improve walking ability in patients with multiple sclerosis. The drug functions by enhancing nerve signal conduction, with approximately 5,000 patients currently eligible for the treatment.

BBC Newsabout 20 hours agoGBscoCredibility 31%View source

Score Breakdown

Mosaic Score5.3
Confidence0.9
Significance0.5
Source credibility0.3

Intelligence Tags

#nhs#multiple sclerosis#pharmaceuticals#healthcare policy

Locations

England

Entities

country
Source

Related signals

8 found